RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit.
Sheikh A, Campbell H, Balharry D, Baqui AH, Bogaert D, Cresswell K, Cunningham S, Dockerell D, El Arifeen S, Fletcher M, Grant L, Ghazali SS, Habib M, Hazir T, Isaac R, Juvekar S, Khoo EM, McKinstry B, Morris AD, Nair H, Norrie J, Nwaru BI, Pinnock H, Robertson D, Saha S, Salvi S, Schwarze J, Simpson C, Sridhar D, Stoddart A, Weller D, Whyte M, Worth A, Williams S, Yusuf O, Zumla A, Rudan I; RESPIRE Collaboration.
J Glob Health. 2018 Dec;8(2):020101. doi: 10.7189/jogh.08.020101. No abstract available.
Zumla A, Abubakar I.
BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.
Universal health coverage for refugees and migrants in the twenty-first century.
Abubakar I, Zumla A.
BMC Med. 2018 Nov 26;16(1):216. doi: 10.1186/s12916-018-1208-2.
Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.
Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.
Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F.
Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. Review.
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study.
Murphy ME, Wills GH, Murthy S, Louw C, Bateson ALC, Hunt RD, McHugh TD, Nunn AJ, Meredith SK, Mendel CM, Spigelman M, Crook AM, Gillespie SH; REMoxTB consortium.
BMC Med. 2018 Oct 17;16(1):189. doi: 10.1186/s12916-018-1169-5.
Advancing global tuberculosis control after the UNGA-HLM.
Marais B, Zumla A.
Lancet. 2018 Sep 29;392(10153):1096-1097. doi: 10.1016/S0140-6736(18)32361-4. Epub 2018 Sep 24. No abstract available.
Zumla A, Petersen E.
Int J Infect Dis. 2018 Oct;75:118-120. doi: 10.1016/j.ijid.2018.09.017. Epub 2018 Sep 19. No abstract available.
Heuvelings CC, Greve PF, de Vries SG, Visser BJ, Bélard S, Janssen S, Cremers AL, Spijker R, Shaw E, Hill RA, Zumla A, Sandgren A, van der Werf MJ, Grobusch MP.
BMJ Open. 2018 Sep 8;8(9):e019642. doi: 10.1136/bmjopen-2017-019642.
Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M.
J Med Virol. 2018 Nov;90(11):1757-1764. doi: 10.1002/jmv.25269. Epub 2018 Aug 13.
Silva DR, Mello FCQ, Kritski A, Dalcolmo M, Zumla A, Migliori GB.
J Bras Pneumol. 2018 Apr;44(2):71-72. doi: 10.1590/s1806-37562018000020001. English, Portuguese. No abstract available.
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.
Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, D'Ambrosio L, Visca D, Rendon A, Gaga M, Zumla A, Migliori GB.
J Bras Pneumol. 2018 Apr;44(2):153-160. doi: 10.1590/s1806-37562017000000436. Review. Portuguese, English.
Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium.
BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3.
Mer M, Zumla A, Dünser MW.
Intensive Care Med. 2018 Dec;44(12):2229-2231. doi: 10.1007/s00134-018-5161-5. Epub 2018 May 11. No abstract available.
Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage.
Gautret P, Okolo S, Elachola H, Zumla A, Memish ZA.
Travel Med Infect Dis. 2018 May - Jun;23:99-100. doi: 10.1016/j.tmaid.2018.04.016. Epub 2018 Apr 27. No abstract available.
Global spread of antibiotic-resistant bacteria and mass-gathering religious events.
Zumla A, Azhar EI, Hui DS, Shafi S, Petersen E, Memish ZA.
Lancet Infect Dis. 2018 May;18(5):488-490. doi: 10.1016/S1473-3099(18)30242-1. No abstract available.
Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A.
Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18. Review.
Floyd K, Glaziou P, Zumla A, Raviglione M.
Lancet Respir Med. 2018 Apr;6(4):299-314. doi: 10.1016/S2213-2600(18)30057-2. Review.
Tuberculosis research and development: seeding the future.
Lienhardt C, Zumla A, Gebreselassie N, Frick M, Gray G, Kasaeva T, Raviglione M.
Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X. No abstract available.
B cells or T cells in TB: a continuing conundrum.
Maeurer M, Rao M, Zumla A.
Lancet Respir Med. 2018 Apr;6(4):237-238. doi: 10.1016/S2213-2600(18)30080-8. No abstract available.
Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A.
Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23. Review. Erratum in: Lancet Infect Dis. 2018 Apr 27;:.
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.
Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A.
Lancet Infect Dis. 2018 Jul;18(7):e199-e210. doi: 10.1016/S1473-3099(18)30111-7. Epub 2018 Mar 23. Review.
Concrete action now: UN High-Level Meeting on Tuberculosis.
Herbert N, Sharma V, Masham BS, Sheehan BS, Hauser J, Zumla A.
Lancet Infect Dis. 2018 Jul;18(7):709-710. doi: 10.1016/S1473-3099(18)30171-3. Epub 2018 Mar 23. No abstract available.
Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A.
Int J Infect Dis. 2018 Mar;68:122-124. doi: 10.1016/j.ijid.2018.03.002. Epub 2018 Mar 22. No abstract available.
Otu A, Hashmi M, Mukhtar AM, Kwizera A, Tiberi S, Macrae B, Zumla A, Dünser MW, Mer M.
J Crit Care. 2018 Jun;45:184-196. doi: 10.1016/j.jcrc.2018.03.015. Epub 2018 Mar 13. Review.
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.
Vjecha MJ, Tiberi S, Zumla A.
Nat Rev Drug Discov. 2018 Sep;17(9):607-608. doi: 10.1038/nrd.2018.28. Epub 2018 Mar 23.
Urgent need for multi-site controlled trials for CMV pneumonia treatment in African children.
Tembo J, Moraleda C, Rojo P, Zumla A, Bates M.
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):469-470. doi: 10.5588/ijtld.17.0847. No abstract available.
Rao M, Valentini D, Zumla A, Maeurer M.
Int J Infect Dis. 2018 Apr;69:78-84. doi: 10.1016/j.ijid.2018.02.021. Epub 2018 Mar 2.
Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA.
J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C?
Ippolito G, Zumla A, Lanini S.
Clin Microbiol Infect. 2018 Apr;24(4):328-331. doi: 10.1016/j.cmi.2018.01.001. Epub 2018 Jan 8. Review. No abstract available.
Lanini S, Portella G, Vairo F, Di Caro A, Kobinger G, Zumla A, Ippolito G.
Clin Infect Dis. 2018 Apr 17;66(9):1480-1481. doi: 10.1093/cid/cix1026. No abstract available.
Advancing political will to end the tuberculosis epidemic.
Herbert N, Masham BS, Suttie BA, Sharma V, Albani S, Domenti O, Flurry R, Oliver M, Zumla A.
Lancet Infect Dis. 2018 Jul;18(7):711-712. doi: 10.1016/S1473-3099(17)30679-5. Epub 2017 Nov 15. No abstract available.
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study.
Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S, Brogiato G, Amone J, Castilletti C, Miccio R, Capobianchi MR, Strada G, Zumla A, Di Caro A, Ippolito G; INMI-EMERGENCY EBOV Sierra Leone Study Group .
Clin Infect Dis. 2018 Jan 6;66(1):36-44. doi: 10.1093/cid/cix704.